Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers

This study has been completed.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Jan Beumer, University of Pittsburgh Identifier:
First received: August 7, 2008
Last updated: December 17, 2013
Last verified: December 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)